ReviewMolecules (Basel, Switzerland)2022

Accum™ Technology: A Novel Conjugable Primer for Onco-Immunotherapy.

Abed El-Hakim El-Kadiry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.